Following the introduction of pneumococcal conjugate vaccines (PCVs) in Mexico, children’s burden of pneumococcal meningitis decreased significantly, according to a study published in the Journal of Infection and Public Health.1
However, with the continued prominence of nonvaccine and commonly appearing pneumococcal serotypes, higher-valent PCVs are necessary to manage pneumococcal surveillance and evaluation in the future.
“Immunization with PCVs has been particularly effective in reducing the burden of pneumococcal meningitis,” wrote the authors of the study.1 “However, the emergence and expansion of non-vaccine Streptococcus pneumoniae…